Business Description
OrthoPediatrics Corp
NAICS : 339115
SIC : 3841
ISIN : US68752L1008
Total Employee Number:
602Description
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.46 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | -21.93 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.03 | |||||
Beneish M-Score | -2.75 | |||||
WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.9 | |||||
3-Year EBITDA Growth Rate | 6.8 | |||||
3-Year EPS without NRI Growth Rate | -6.8 | |||||
3-Year FCF Growth Rate | 23.5 | |||||
3-Year Book Growth Rate | -5.9 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 59.13 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 12.15 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 15.28 | |||||
9-Day RSI | 31.45 | |||||
14-Day RSI | 42.05 | |||||
3-1 Month Momentum % | 24.9 | |||||
6-1 Month Momentum % | 26.15 | |||||
12-1 Month Momentum % | 8.9 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 4.78 | |||||
Quick Ratio | 2.17 | |||||
Cash Ratio | 0.87 | |||||
Days Inventory | 722.94 | |||||
Days Sales Outstanding | 79.23 | |||||
Days Payable | 88.33 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -3.1 | |||||
Shareholder Yield % | -3.59 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 73.65 | |||||
Operating Margin % | -9.01 | |||||
Net Margin % | -15.72 | |||||
EBITDA Margin % | -1.8 | |||||
FCF Margin % | -0.73 | |||||
OCF Margin % | 2.93 | |||||
ROE % | -11.46 | |||||
ROA % | -7.88 | |||||
ROIC % | -5.32 | |||||
ROC (Joel Greenblatt) % | -13.32 | |||||
ROCE % | -5.84 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 2.06 | |||||
PB Ratio | 1.67 | |||||
Price-to-Tangible-Book | 3.86 | |||||
Price-to-Operating-Cash-Flow | 70.03 | |||||
EV-to-EBIT | -23.37 | |||||
EV-to-EBITDA | -138.21 | |||||
EV-to-Forward-EBITDA | 213.69 | |||||
EV-to-Revenue | 2.48 | |||||
EV-to-Forward-Revenue | 2.12 | |||||
EV-to-FCF | -342.18 | |||||
Price-to-GF-Value | 0.73 | |||||
| Price-to-Net-Current-Asset-Value | 6.77 | |||||
Earnings Yield (Greenblatt) % | -4.28 | |||||
FCF Yield % | -0.32 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:KIDS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
OrthoPediatrics Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 252.725 | ||
| EPS (TTM) ($) | -1.68 | ||
| Beta | 1.1293 | ||
| 3-Year Sharpe Ratio | -0.35 | ||
| 3-Year Sortino Ratio | -0.45 | ||
| Volatility % | 38.62 | ||
| 14-Day RSI | 42.05 | ||
| 14-Day ATR ($) | 0.950747 | ||
| 20-Day SMA ($) | 24.2195 | ||
| 12-1 Month Momentum % | 8.9 | ||
| 52-Week Range ($) | 14.42 - 26.74 | ||
| Shares Outstanding (Mil) | 26.11 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
OrthoPediatrics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
OrthoPediatrics Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Annual report for 2026 | 2027-03-04 | In 176 days | ||
| Fourth quarter earnings conference call for 2026 | 2027-02-26 16:30 | In 171 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-26 | In 170 days | ||
| Third quarter earnings conference call for 2026 | 2026-10-28 16:30 | In 50 days | ||
| Third quarter earnings results for 2026 | 2026-10-28 | In 49 days | ||
| Canaccord Genuity 46th Annual Growth Conference | 2026-08-12 09:00 | 24.24 (+4.03%) | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 16:30 | 20.87 (+2.10%) | ||
| Second quarter earnings results for 2026 | 2026-08-04 | 20.87 (+2.10%) | ||
| Guidance call for 2026 | 2026-06-08 14:40 | 18.32 (+1.55%) | ||
| General meeting for 2026 | 2026-06-04 11:30 | 16.92 (+1.08%) |
Show
Entries
OrthoPediatrics Corp Frequently Asked Questions
What is OrthoPediatrics Corp(KIDS)'s stock price today?
The current price of KIDS is $21.99. The 52 week high of KIDS is $26.74 and 52 week low is $14.42.
When is next earnings date of OrthoPediatrics Corp(KIDS)?
The next earnings date of OrthoPediatrics Corp(KIDS) is 2026-10-28 Est..
Does OrthoPediatrics Corp(KIDS) pay dividends? If so, how much?
OrthoPediatrics Corp(KIDS) does not pay dividend.
Guru Commentaries on NAS:KIDS
Minot Light Capital Partners
Neutral
2026 Q1
What the manager wrote
Orthopediatrics (KIDS) is mentioned as a top 10 name in the portfolio and a large detractor due to its relative size and normal volatility. The manager indicates that they continue to own all of their top-5 detractors this quarter and have been buying more of these names recently, suggesting a commitment to the position despite its current performance.
Press Release
Articles on OrthoPediatrics Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers